Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The company was founded in 2011 and is based in Bloomington, Minnesota.
Price analytics
Returns
1 day
0.0%
1 week
1.2%
1 month
0.0%
3 months
-16.2%
6 months
-48.4%
1 year
—
3 years
—
Risk
Volatility (1y ann.)
84.6%
Beta vs ASX 200
0.77
Sharpe (1y)
-1.23
VaR 95% (1-day)
-6.7%
Max drawdown (1y)
-76.5%
Off 1-year high
-73.0%
Technicals
RSI(14)
47
vs 50DMA
-14.7%
vs 200DMA
-42.1%
Trend
Death cross
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value98.1
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
92
Price / Sales
—
Growth100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health49.7
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
10
Quality (Profitability & Cash Flow)0.0
Return on equity
—
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum0.8
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
4
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).